We also find that the vast majority of subjects who are approved to take these drugs are not taking them, and a significant number who are not approved to take the drugs are taking them. We find strong evidence that the well-publicized 1997 withdrawal of fenfluramine and dexfenfluramine had a chilling effect on the overall market for anti-obesity drugs. We find little difference in observed characteristics between those who took the withdrawn drugs and those who took the other anti-obesity drugs in the market.
Cawley, J. and Rizzo, J. (2006), "One Pill Makes you Smaller: The Demand for Anti-Obesity Drugs", Bolin, K. and Cawley, J. (Ed.) The Economics of Obesity (Advances in Health Economics and Health Services Research, Vol. 17), Emerald Group Publishing Limited, Bingley, pp. 149-183. https://doi.org/10.1016/S0731-2199(06)17007-7Download as .RIS
Emerald Group Publishing Limited
Copyright © 2006, Emerald Group Publishing Limited